- In July 2024, a study conducted by a team led by Huan Tang and Jigang Wang from the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences demonstrated that Cordyceps Sinensis has the potential to alleviate idiopathic pulmonary fibrosis in mice. This research focuses on mitochondrion-mediated oxidative stress inhibition, showcasing Cordyceps' therapeutic effects in treating this debilitating lung disease. The development is a significant step forward in exploring natural remedies for respiratory conditions, providing a potential treatment option for idiopathic pulmonary fibrosis. This breakthrough could positively impact the Cordyceps Sinensis market, as the growing recognition of its medicinal benefits may lead to increased demand for Cordyceps-based products in the health and pharmaceutical industries
